FIAflex™ CEA (Carcinoembryonic Antigen) FIA Test

The FIAflex™ CEA FIA Test is a fluorescence immunoassay designed for the quantitative measurement of Carcinoembryonic Antigen (CEA) using the FIAflex Fluorescent Immunoassay Analyzer. CEA is a tumor-associated marker used by healthcare professionals primarily to help monitor certain cancers, assess response to treatment and detect possible recurrence, particularly in colorectal cancer. CEA results should be interpreted together with clinical findings and other diagnostic investigations rather than used alone to diagnose cancer. The test is designed for use within the FIAflex fluorescence immunoassay platform, which provides instrument-based fluorescence measurement and digital result interpretation. Key Features Quantitative CEA measurement Tests Carcinoembryonic Antigen Fluorescence immunoassay technology Analyzer-based result interpretation Designed for FIAflex analyzer use Suitable for tumor-marker testing Compact immunoassay test format Suitable for professional clinical laboratories Supports cancer-monitoring workflows Digital fluorescence-based measurement Professional in-vitro diagnostic application